T helper 2-dominant antilymphoma immune response is associated with fatal outcome

Blood

Volumn 90, Issue 4, 1997, Pages 1611-1617

  Lee, Peter P ^b   Zeng, Defu ^b   McCaulay, Ann E ^b   Chen, Yan Fei ^b   Geiler, Craig ^b   Umetsu, Dale T ^b   Chao, Nelson J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CANCER IMMUNOLOGY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; HELPER CELL; LYMPHOCYTE PROLIFERATION; LYMPHOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030824806     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1611     Document Type: Article

References (19)

1. Kurzrock R, Kantarjian H, Wetzler M, Estrov Z, Estey E, Troutman-Worden K, Gutterman JU, Talpaz M: Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage. Exp Hematol 21:80, 1993
2. Bost KL, Bieligk SC, Jaffe BM: Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. Tumorderived IL-10 as a possible mechanism for modulating the antitumor response. J Immunol 154:718, 1995
3. Hao W, McDonald TL, Brunson KW, Joshi SS: Enhanced immunosuppressive activity associated with metastatic lymphoma cells. Cancer Res 53:1921, 1993
4. Bogen B, Weiss S: Processing and presentation of idiotypes to MHC-restricted T cells. Int Rev Immunol 10:337, 1993
5. Secrist H, DeKruyff RH, Umetsu DT: Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 181:1081, 1995
6. Umetsu DT, Esserman L, Donlon TA, DeKruyff RH, Levy R: Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J Immunol 144:2550, 1990
7. Lasky JL, Thorbecke GJ: Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines. Eur J Immunol 19:365, 1989
8. Slavin S, Strober S: Spontaneous murine B-cell leukemia. Nature 272:624, 1978
9. Strober S, Gronowicz ES, Knapp MR, Slavin S, Vitetta ES, Warnke RA, Kotzin B, Schroder J: Immunobiology of a spontaneous murine B cell leukemia (BCL1). Immunol Rev 48:169, 1979
10. Matzinger P: The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185, 1991
11. Murphy E, Hieny S, Sher A, O'Garra A: Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice. J Immunol Methods 162:211, 1993
12. Murphy E, Shibuya K, Hosken N, Openshaw P, Maino V, Davis K, Murphy K, O'Garra A: Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med 183:901, 1996
13. Chehimi J, Trinchieri G: Interleukin-12: A bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J Clin Immunol 14:149, 1994
14. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM: Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 171:115, 1990
15. Penn I: Tumors of the immunocompromised patient. Annu Rev Med 39:63, 1988
16. Challis GB, Stam HJ: The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol 29:545, 1990
17. Hankey BF, Steinhorn SC: Long-term patient survival for some of the more frequently occurring cancers. Cancer 50:1904, 1982
18. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92:11810, 1995
19. Rocken M, Shevach EM: Immune deviation-The third dimension of nondeletional T cell tolerance. Immunol Rev 149:175, 1996